首頁 > 市場調查報告書 > 食物/飲料

機能性食品

臨床營養市場規模、佔有率和成長分析（按給藥途徑、分銷管道、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1904805

臨床營養市場規模、佔有率和成長分析（按給藥途徑、分銷管道、最終用戶和地區分類）－2026-2033年產業預測

Clinical Nutrition Market Size, Share, and Growth Analysis, By Route of Administration (Oral, ParenteralCancer), By Distribution Channel, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，臨床營養市場規模將達到 417.6 億美元，到 2025 年將達到 450.6 億美元，到 2033 年將達到 827.8 億美元，預測期（2026-2033 年）的複合年成長率為 7.9%。

臨床營養在改善代謝功能方面發揮著至關重要的作用，它提供人體必需的營養素，例如維生素和礦物質，這些營養素對提升健康至關重要。該領域專注於解決影響食物攝取、消化和代謝的各種問題，同時致力於預防與飲食相關的疾病。臨床營養在多種場景中都至關重要，包括心臟復健、腎臟護理、糖尿病管理、小兒科、癌症治療和社區健康計畫。文明病的日益增加和人口老化正在推動對臨床營養解決方案的需求。此外，政府對醫學研究投入的不斷增加以及營養產品在居家照護中的廣泛應用也進一步促進了市場成長。亞太和拉丁美洲等新興市場蘊藏著巨大的機遇，使臨床營養成為一個極具吸引力的投資領域。

臨床營養市場促進因素

社會老化正對臨床營養市場的發展產生重大影響。隨著老齡化，人們的活動量下降、新陳代謝減慢、能量需求降低，同時營養吸收和利用也面臨挑戰。這些變化增加了老年人的營養需求，從而推動了對能夠改善能量吸收和利用的專用臨床營養產品的需求。這些因素對於推動市場成長至關重要，因為老年人在努力維持健康和生活品質的過程中，對個人化營養解決方案的需求日益凸顯。

臨床營養市場中的阻礙因素

儘管對治療性營養的需求日益成長，但人們對醫療和飲食實踐的認知仍然不足。這種對臨床營養益處的理解不足在已開發國家和開發中國家都普遍存在。此外，關於維生素和飲食實踐的錯誤訊息傳播加劇了營養缺乏和相關健康問題。因此，臨床營養方面存在的巨大知識鴻溝和普遍誤解是阻礙臨床營養市場成長的主要挑戰。這些因素阻礙了潛在的進步，並透過限制臨床營養解決方案的更廣泛接受和應用，限制了市場擴張。

臨床營養市場趨勢

臨床營養市場正經歷顯著成長，這主要得益於醫療基礎設施的不斷完善以及對先進醫療解決方案日益成長的需求，尤其是在亞太和拉丁美洲、中東和非洲（LAMEA）等新興地區。文明病疾病和慢性病的增加，使得人們更迫切地需要全面的營養支持來應對營養不良和飲食挑戰。此外，針對呼吸系統疾病、腎臟疾病和癌症等各種健康狀況的醫療設備的持續研發和創新，也進一步推動了市場需求。醫療技術的進步與飲食需求的融合，凸顯了向滿足不同患者需求的綜合性臨床營養解決方案發展的強勁趨勢。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Abbott Laboratories（US）
Nestle Health Science（Switzerland）
Danone Nutricia（France）
Fresenius Kabi（Germany）
Baxter International（US）
B. Braun Melsungen AG（Germany）
Mead Johnson Nutrition（Reckitt）（US）
GlaxoSmithKline（GSK）（UK）
Pfizer（US）
Ajinomoto Co., Inc.（Japan）
Koninklijke DSM NV（Netherlands）
Lonza Group（Switzerland）
Cambrooke Therapeutics（US）
Sichuan Kelun Pharmaceutical Co. Ltd.（China）
Otsuka Pharmaceutical（Japan）
Hormel Health Labs（US）
Perrigo Company（Ireland）
Hero Group（Switzerland）
Victus（US）
Entrocare Nutritional Solutions（UK）

結論與建議

簡介目錄

Product Code: SQMIG30A2012

Clinical Nutrition Market size was valued at USD 41.76 Billion in 2024 and is poised to grow from USD 45.06 Billion in 2025 to USD 82.78 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

Clinical nutrition plays a pivotal role in enhancing metabolic function by supplying essential nutrients, such as vitamins and minerals, crucial for improving health outcomes. This field focuses on addressing conditions impacting food intake, digestion, and metabolism, while also working to prevent diet-related diseases. Clinical nutrition is vital in diverse settings, including cardiac rehabilitation, renal care, diabetes management, pediatrics, cancer treatment, and community wellness programs. The escalating prevalence of lifestyle-related diseases and an aging population are driving the demand for clinical nutrition solutions. Additionally, increased government funding in healthcare research and a surge in nutritional product usage for home care further catalyze market growth. Emerging markets in Asia-Pacific and Latin America present significant opportunities, making clinical nutrition an appealing investment landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Nutrition Market Segments Analysis

Global Clinical Nutrition Market is segmented by Route of Administration, application, Distribution Channel, end user, Nutritional Content and region. Based on Route of Administration, the market is segmented into Oral, Parenteral, and Enteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorder, Metabolic Disorder, and Others. Based on Distribution Channel, the market is segmented into Online and Offline. Based on end user, the market is segmented into Paediatric, Adults, and Geriatric. Based on By Nutritional Content, the market is segmented into Protein-Based Nutrition, Vitamin and Mineral-Rich Nutrition, Carbohydrate-Based Nutrition, and Fat-Based Nutrition. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Clinical Nutrition Market

The growing elderly population is significantly influencing the development of the clinical nutrition market. As individuals age, they typically experience reduced activity levels, a decline in metabolic rates, and diminished energy demands, alongside challenges in nutrient absorption and utilization. This decline leads to heightened nutritional requirements among older adults, driving the demand for specialized clinical nutrition products that enhance energy absorption and utilization. Consequently, these factors are essential in fostering market growth, as the need for tailored nutritional solutions becomes increasingly prominent among aging populations seeking to maintain their health and well-being.

Restraints in the Clinical Nutrition Market

Despite a growing demand for therapeutic nutrition, awareness around healthcare and dietary practices remains low. This lack of understanding regarding the benefits of clinical nutrition exists in both developed and developing countries. Additionally, the spread of incorrect information regarding vitamins and dietary practices contributes to deficiencies and related health issues. As a result, the significant gaps in knowledge surrounding clinical nutrition, along with general misconceptions, represent major challenges that inhibit the growth of the clinical nutrition market. These factors hinder potential advancements and limit the market's expansion by preventing broader acceptance and utilization of clinical nutrition solutions.

Market Trends of the Clinical Nutrition Market

The clinical nutrition market is experiencing significant growth, particularly in emerging regions such as Asia-Pacific and LAMEA, driven by enhanced healthcare infrastructure and a rising demand for advanced healthcare solutions. The increasing prevalence of lifestyle-related and chronic diseases is creating urgent needs for comprehensive nutritional support, addressing malnutrition and dietary challenges. Additionally, ongoing research and innovation in medical devices aimed at managing various health conditions, including respiratory, renal, and cancer-related issues, are further propelling market demand. This convergence of healthcare advancements and dietary needs underscores a robust trend toward integrated clinical nutrition solutions tailored to diverse patient requirements.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Regulatory Landscape
Patent Analysis
Value Chain Analysis
PESTEL Analysis
Market Attractiveness Index
Raw Material Analysis
Pricing Analysis

Global Clinical Nutrition Market Size by Route of Administration & CAGR (2026-2033)

Market Overview
Oral
Parenteral
Enteral

Global Clinical Nutrition Market Size by Application & CAGR (2026-2033)

Market Overview
Cancer
Neurological Diseases
Gastrointestinal Disorder
Metabolic Disorder
Others

Global Clinical Nutrition Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Online
Offline
- Retail Stores
- Institutional Sales Channel
- Others

Global Clinical Nutrition Market Size by End User & CAGR (2026-2033)

Market Overview
Pediatrics
Adults
Geriatric

Global Clinical Nutrition Market Size by Nutritional Content & CAGR (2026-2033)

Market Overview
Protein-Based Nutrition
Vitamin and Mineral-Rich Nutrition
Carbohydrate-Based Nutrition
Fat-Based Nutrition

Global Clinical Nutrition Market Size & CAGR (2026-2033)

North America, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
- US
- Canada
Europe, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
- Brazil
- Rest of Latin America
Middle East & Africa, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Abbott Laboratories (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nestle Health Science (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danone Nutricia (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mead Johnson Nutrition (Reckitt) (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline (GSK) (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ajinomoto Co., Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke DSM N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cambrooke Therapeutics (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sichuan Kelun Pharmaceutical Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Otsuka Pharmaceutical (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hormel Health Labs (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hero Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Victus (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Entrocare Nutritional Solutions (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments